Volume 13, Issue 1 (2022)                   JMBS 2022, 13(1): 107-119 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Vahedian Sadeghi R, Parsania M, Sadeghizadeh M, Haghighat S, Mortazavi Farsani S S. A Comparison of Curcumin and Nanocurcumin Effect on the expression of the vascular endothelial growth factor (VEGF-A) in HeLa cell line. JMBS 2022; 13 (1) :107-119
URL: http://biot.modares.ac.ir/article-22-55786-en.html
1- Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University,Tehran, Iran
2- Department of Microbiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad university, Tehran, Iran. , masoud_parsania@yahoo.com
3- Genetics Department, BiologicalSciences Faculty, Tarbiat ModaresUniversity, Tehran, Iran
4- Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University,Tehran,Iran.
5- Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
Abstract:   (1614 Views)
Introduction: Cervical cancer is the fourth most common cancer among women. In recent years, attention has increased to natural products such as curcumin with anti-cancer potential as a therapeutic supplement. However, due to its poor solubility, its clinical use is limited. In this regard, in this study, to improve clinical parameters, the effects of nanocurcumin on the angiogenesis inhibition of cervical cancer were investigated and compared with free curcumin.
Materials and Methods: MTT method was used to evaluate the proliferation of the HeLa cell line with free curcumin and nanocurcumin at different doses and time intervals and the rate of apoptosis was assessed by flow cytometry. Then, the expression of the vascular endothelial growth factor (VEGF-A) gene in HeLa cells was measured by Real-Time PCR and Western blotting, respectively.
Results: According to IC50 for 48 hours in the HeLa cell line, which was 15 μM/ml and 50 μM/ml for nanocurcumin and free curcumin, respectively, the nanocurcumin showed a greater lethal effect. VEGF-A gene expression (p <0.0001) and protein level (p <0.01) were significantly lower following nano-curcumin treatment than free curcumin.
Conclusion: Nanocarrier increased the solubility and further inhibited the proliferation of cervical cancer HeLa cells and was three times more effective than curcumin in inhibiting angiogenesis at the same concentration. Therefore, nanocurcumin can be a good option for drug supplementation along with routine cervical cancer treatment.
Keywords: Cervical cancer, Nanocurcumin, HeLa cell, VEGF-A.
Full-Text [PDF 511 kb]   (469 Downloads)    
Article Type: Original Research | Subject: Pharmaceutical Biotechnology
Received: 2021/09/21 | Accepted: 2021/11/28 | Published: 2023/01/4

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.